Introduction
============

Aortic atheroma (AA) is an atherosclerotic change in proximal and distal aorta or aortic arch. AA is regarded as high risk for occurrence and recurrence of ischemic stroke and poor long-term outcomes \[[@b1-jos-2016-00171],[@b2-jos-2016-00171]\]. Association between AA and cerebral large artery atherosclerosis had been confirmed not only in pathologic studies \[[@b3-jos-2016-00171]\] but also in clinical studies in patients with ischemic stroke \[[@b4-jos-2016-00171],[@b5-jos-2016-00171]\]. Transesophageal echocardiography (TEE) is a useful tool for identification of AA. Presence of AA may indicate the presence of atherosclerosis in other vascular beds \[[@b4-jos-2016-00171]\].

Cerebral small vessel diseases (SVDs) including cerebral microbleeds (CMBs), white matter hyperintesities (WMHs), perivascular spaces (PVSs) and asymptomatic lacunar infarctions (ALIs) are associated with both ischemic and hemorrhagic stroke \[[@b6-jos-2016-00171],[@b7-jos-2016-00171]\]. Like AA, these SVDs had been reported that association of recurrence and progression of ischemic stroke \[[@b8-jos-2016-00171]\].

Patients with either AAs or SVDs frequently have common vascular risk factors including old age and hypertension \[[@b9-jos-2016-00171],[@b10-jos-2016-00171]\]. Apart from the association with stroke risk factors, AAs are known to make injury to brain via direct (such as embolic ischemic damage) and/or indirect mechanism (such as increased arterial stiffness by AAs) \[[@b11-jos-2016-00171],[@b12-jos-2016-00171]\]. Even though many studies reported the association between large artery atherosclerosis and SVDs \[[@b13-jos-2016-00171]\], the studies for the relationship between AA and SVDs are limited \[[@b14-jos-2016-00171]\]. In this regards, we intended to investigate the relationship between presence and burden of AAs and those of coexisting SVDs in patients with acute ischemic stroke.

Methods
=======

Subjects
--------

Subjects for this study were drawn from consecutive patients with acute ischemic stroke who were registered in the Yonsei Stroke Registry \[[@b15-jos-2016-00171]\]. The Yonsei Stroke Registry is a prospective hospital-based registry of patients with cerebral infarction or transient ischemic attack within 7 days after symptom onset \[[@b16-jos-2016-00171]\]. During admission, all patients were evaluated according to the standard stroke evaluation that includes brain imaging (computed tomography and/or magnetic resonance imaging \[MRI\]), vascular imaging studies (digital subtraction angiography, MR angiography, or computed tomography angiography), plain chest X-ray, 12-lead electrocardiography and cardiac echocardiography including TEE. Stroke subtype was determined according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification \[[@b17-jos-2016-00171],[@b18-jos-2016-00171]\]. Briefly, large artery atherosclerosis is defined as significant (≥50%) stenosis of the large artery relevant to the acute infarction. The presence of complex aortic plaque (CAP) was considered as one form of large artery atherosclerosis. Cardioembolism is defined as at least one potential cardiac source of embolism based on the TOAST classification. A patient with lacunar infarction should have one of the classic clinical lacunar syndromes and a relevant subcortical hemispheric or brain stem lesion with diameter \<1.5 cm \[[@b16-jos-2016-00171]\]. Besides above method of the TOAST classification, we reclassified the TOAST classification. In that reclassification, CAPs were not considered as large artery atherosclerosis. The Institutional Review Board of Severance Hospital, Yonsei University Health System, approved this study and waived the need for patient informed consent because of the retrospective design and observational nature of the study.

Transesophageal echocardiography
--------------------------------

TEE was performed within 2 weeks of initial stroke or transient ischemic attack. TEE was a component of standard evaluation for patients in the study hospital \[[@b16-jos-2016-00171]\] and was performed in all patients except for those with altered consciousness, progressing brain herniation, poor systemic condition, tracheal intubation, failure to introduce an esophageal transducer, or lack of informed consent. Detailed method of performing TEE was described in [supplemental methods](#SD1){ref-type="supplementary-material"} \[[@b19-jos-2016-00171]\]. Maximal thickness of plaques was used in this study. AAs were classified as CAP or simple aortic plaque (SAP). CAPs consisted of plaques protruding into the lumen by ≥4 mm and mobile lesions located in the proximal aorta. SAPs were plaques \<4 mm in the proximal aorta or plaques of any size located in the descending aorta \[[@b20-jos-2016-00171]\]. Patients who had both CAP and SAP were categorized into the CAP group because CAP is a more advanced form of AA and is regarded a potential cause of stroke. Two cardiologists who are experts in echocardiography interpreted the TEE results. In cases of discrepancy, the final decision was made by consensus \[[@b3-jos-2016-00171],[@b19-jos-2016-00171]\].

Risk factors and definitions of variables
-----------------------------------------

The clinical variables including risk factors (hypertension, diabetes mellitus, hyperlipidemia, current smoking, coronary artery disease, the patient's prior medication and metabolic syndrome) were described as based on previous studies. The detail definition of clinical variables was elucidated in [supplementary methods](#SD1){ref-type="supplementary-material"}.

MRI protocol and cerebral small vessel diseases
-----------------------------------------------

All MRI examinations were performed on a 3.0T MRI machine (Achieva 3.0T; Philips Medical Systems, Best, Netherlands or MAGNETOM 3.0T Trio; Siemens, Germany). Parameters of diffusion-weighted imaging were time repetition/time echo=2,600-6,500/42-70 ms, 2-mm inter-slice gap, field of view=230×230 mm, and slice thickness=5 mm. Two b-values (0, 1,000) in six different directions of diffusion gradient (x, y, z, xy, yz, zx) were calculated. The fluid-attenuated inversion recovery image was performed with time repetition/time echo=9,000/120 ms, pixel spacing=0.449 mm/0.449 mm, field of view=230×230 mm, and slice thickness=5 mm. The gradient recalled echo images were obtained at time repetition/time echo=600/16 ms, pixel spacing=0.449 mm/0.449 mm, field of view=250×250 mm, and slice thickness=5 mm.

Cerebral SVDs, including CMBs, WMHs, PVSs, and ALIs, were defined according to MRI findings ([Figure 1](#f1-jos-2016-00171){ref-type="fig"}). All lesions of SVDs should not be located in acute infarctions on diffusion-weighted imaging ([Supplementary Figure 1](#SD6){ref-type="supplementary-material"}, [2](#SD7){ref-type="supplementary-material"}) \[[@b21-jos-2016-00171]\]. CMBs were indicated as punctate hypointense lesion less than 10 mm in size and located in brain parenchyma \[[@b22-jos-2016-00171]\]. For this study, CMBs were classified as strictly lobar or non-lobar. Strictly lobar CMBs were defined as CMBs located only in the lobar location, whereas non-lobar CMBs were found in the non-lobar location, with or without one or more lobar CMBs. Strictly lobar CMBs were defined when a patient had possible or probable cerebral amyloid angiopathy (CAA), as defined previously \[[@b23-jos-2016-00171]\]. We also assessed the severity of WMHs. The extent of WMHs was determined on the fluid-attenuated inversion recovery images of periventricular white matter or deep white matter according to Fazekas' scoring system \[[@b24-jos-2016-00171]\]. A Fazekas score ≥2 in periventricular white matter and/or ≥2 in deep white matter was regarded as high-grade WMHs. PVSs were defined as punctate and/or linear hyperintense lesion in the basal ganglia on T2-weighted images. PVSs were \<3 mm in size and were classified with the following scale: grade 0, no PVS; grade 1, 1-10 PVSs; grade 2, 11-20 PVSs; grade 3, 21-40 PVSs; and grade 4, ≥40 PVSs. High-grade PVSs were defined when lesions of grade 2-4 were found in the basal ganglia and centrum semiovale \[[@b25-jos-2016-00171]\]. ALIs were defined when the patients had no history of symptoms or signs of previous stroke. The imaging criterion of ALIs was one or more cavitary lesions with high-signal lesions on fluid-attenuated inversion recovery and T2-weighted images and low signal intensities on T1-weighted images. Size limitation of ALIs was ≥3 mm and \<15 mm \[[@b26-jos-2016-00171]\]. According to a previous study, total SVD score was calculated by summation of 1 point for the presence of each of CMBs, high-grade WMHs, high-grade PVSs, or ALIs. The range of total SVD score was therefore 0-4 \[[@b27-jos-2016-00171]\]. Two investigators who were blinded to the patient's clinical information independently assessed the presence of SVD lesions. Interobserver agreement (kappa values) for presence of CMBs, high-grade WMHs, high-grade PVSs, and ALIs was 0.92, 0.84, 0.88, and 0.82, respectively. If there was disagreement, a final decision was reached by consensus.

Arterial stiffness
------------------

Arterial stiffness was evaluated by brachial-ankle pulse wave velocity (baPWV). The baPWV was measured using an automated device (VP-1000; Colin Co. Ltd, Komaki, Japan) while the patients were in the supine position. After resting for 5 minutes, the pulse wave was simultaneously detected in the upper arms and ankles. Time difference between the upper arm and ankle waveforms was measured automatically.

Statistical analysis
--------------------

Statistical analyses were performed using Windows SPSS package (version 20.0, Chicago, IL, USA). Continuous variables were reported as mean±SD and categorical variables as frequency and percentage. Chi-square test, Fisher exact test, and independent *t* test were used for comparisons. To determine the association between CMBs burden and AA, patients with CMBs were categorized into three groups according to number of CMBs (none, 1-2, and ≥3) \[[@b26-jos-2016-00171]\]. Multivariable analysis was performed using the factors with a *P* value \<0.1 in the univariable analysis. Independent factors of presence of AAs were determined with binary logistic regression analysis. For the existence of CAP and SAP, multinomial logistic regression analysis was used with CAPs and SAPs as dependent variables. Because the variance inflation factor was higher than six among SVDs, each SVD and total SVD score were separately analyzed in multivariable analyses. Statistical significance was set at *P*\<0.05. Odds ratios (OR) and 95% confidence interval (CI) were also calculated.

Results
=======

Study patients
--------------

Among the 1,888 patients who were prospectively registered in the stroke data base, patients with transient ischemic attack (n=177), stroke due to other rare causes (n=45), and incomplete stroke evaluation (n=18) were excluded. Patients without evaluation by TEE (n=759), brain MRI (n=81), gradient recalled echo images (n=35), lack of vascular imaging studies (n=32), or poor image quality (n=4) were also excluded. Finally, a total of 737 patients were included ([Supplemental Figure 3](#SD8){ref-type="supplementary-material"}). Patients who underwent TEE were younger (*P*=0.001), more likely to be smokers (*P*=0.021), and less frequently had a history of stroke (*P*= 0.010) than those without TEE, although the other variables were similar between the groups ([Supplementary Table 1](#SD2){ref-type="supplementary-material"}).

Aortic atheroma and cerebral small vessel diseases
--------------------------------------------------

AA was found by TEE in 360 (48.8%) patients, including 11.6% with CAP and 37.2% with SAP. Patients with AA were older and included a higher proportion of males compared to those without AA. Most risk factors, including hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, and metabolic syndrome were more common in patients with AA. In the TOAST classification, large artery atherosclerosis was similar between patients with AA and those without. Undetermined two or more causes identified were twice as common in patients with AA (27.2%) as those without (14.9%). The undetermined two or more causes identified subtypes were consisted of 59/98 (59.3%) with large artery atherosclerosis plus lacunar infarction, 19/98 (19.4%) with large artery atherosclerosis plus cardioembolism, 17/98 (17.3%) with lacunar infarction plus cardioembolism, and 3/98 (3.0%) with large artery atherosclerosis plus lacunar infarction plus cardioembolism. Undetermined two or more causes identified subtype was more common in patients with CAP (57.0%) than those with SAP (17.9%) ([Table 1](#t1-jos-2016-00171){ref-type="table"}). When we reclassified TOAST classification, patients with CAP more frequently had large artery atherosclerosis or lacunar infarction than those with SAP and without AA (*P*=0.001) ([Supplementary Table 2](#SD3){ref-type="supplementary-material"}).

One or more types of SVDs were found in 269 (36.4%) patients, including 161 (21.8%) CMBs, 218 (29.6%) high-grade WMHs, 152 (20.6%) high-grade PVSs, and 230 (31.2%) ALIs. Among the patients with CMB, 153 (95.0%) had non-lobar CMBs, and 8 (5.0%) had strictly lobar CMBs, including 7 (4.3%) with probable CAA and 1 (0.7%) with possible CAA. Total SVD score=0 was found in 63.2% patients, 1 in 3.1%, 2 in 11.7%, 3 in 11.1%, and 4 in 10.9%. A total SVD score of 1 was found in 23 (3.1%) patients, who most commonly had only CMB (52.1%). In patients with a total SVD score of 2, the most common combination was high-grade WMH plus ALI in 86 patients (76.7%). For patients with a total SVD score of 3, CMB plus high-grade PVS plus ALI was most common and was found in 82 (40.2%) patients. Total SVD score was higher in patients with AA compared to those without and CAP compared to SAP ([Table 2](#t2-jos-2016-00171){ref-type="table"}).

All subtypes of SVDs were common in patients with AA and CAP ([Table 2](#t2-jos-2016-00171){ref-type="table"}). Regarding the location of CMBs, strictly lobar and non-lobar CMBs were more common in patients with AA than in those without (*P*\<0.001). Patients with CAP had high-grade WMHs in both periventricular and deep white matter regions. Number of CMBs, degree of WMHs, and degree of PVSs were highest in patients with CAP, followed by those with SAP, compared to those without AA (*P* for trend \<0.001). Moreover, CAP was more common as burden of total SVD score increased (*P* for trend \<0.001) ([Figure 2](#f2-jos-2016-00171){ref-type="fig"}).

Multivariable analysis of presence of AA
----------------------------------------

Binary logistic regression analysis revealed that patients with AA were 4.68-fold (95% CI 3.01-7.28) more likely to have CMBs compared to those without. High-grade WMHs (OR 3.13, 95% CI 2.15-4.57), high-grade PVSs (OR 3.13, 95% CI 2.15-4.57), and presence of ALIs (OR 4.24, 95% CI 2.90-6.20) were also more common in patients with AA. Both periventricular and deep WMHs were common in patients with AA. Total SVD score ≥2 was independently associated with presence of AA ([Table 3](#t3-jos-2016-00171){ref-type="table"}).

In multinomial logistic regression analysis, patients with CAP (OR 8.72, 95% CI 4.71-16.14) or SAP (OR 3.94, 95% CI 2.48-6.25) more frequently had cerebral SVD. They also more commonly had all subtypes of SVDs. Regarding the location of CMBs, patients with CAP or SAP were more likely to have both non-lobar and strictly lobar CMBs. In particular, patients with CAP were more likely to have strictly lobar CMBs. Total SVD score ≥2 was independently related with presence of CAP or SAP, and each 1-point increase in total SVD score increased the odds of presence of CAP (OR 1.94, 95% CI 1.44-1.85) and SAP (OR 1.54 95% CI 1.35-1.75) ([Table 3](#t3-jos-2016-00171){ref-type="table"}).

Sensitivity analysis of patients who underwent baPWV was conducted. Among total 737 patients, 143 patients who did not performe baPWV were excluded. Then, 174 patients who have potential cardiac sources of embolism were excluded because arrhythmia can prevent accurate measurement of baPWV and steno-occlusive lesions that can be indistinguishable from cardiac embolism \[[@b28-jos-2016-00171]\]. Finally, 420 patients were included in subgroup analysis for relationship between AA and arterial stiffness. Regarding arterial stiffness, increased pulse wave velocity was associated with presence of AA and higher burden of AA (CAP) but not SAP ([Supplementary Table 3](#SD4){ref-type="supplementary-material"}).

When applying reclassification of the TOAST classification, index acute lacunar infarction was not related with presence of AA but there were trend of their association (OR 1.67, 95% CI 0.93-2.99). Whereas the index lacunar infarction was independently associated with CAP (OR 3.27, 95% CI 1.51-7.08) but not with SAP (OR 1.19, 95% CI 0.61-2.30) ([Supplementary Table 4](#SD5){ref-type="supplementary-material"}).

Discussion
==========

We demonstrated that patients with AA not only frequently had coexisting SVDs, but also had a higher burden of coexisting SVDs as measured by total SVD score. Patients with AA had higher numbers of CMBs, higher grade WMHs, and higher grade PVSs compared to those without AA. Among subtypes of AAs, patients with CAP, and to a lesser extent those with SAP, had a higher number of CMBs, a higher degree of WMHs, high-grade PVSs than those without AA.

Few studies have reported the association between AA and coexisting SVDs. As mentioned above, a case control study showed that presence of proximal AA was associated with lacunar infarction \[[@b14-jos-2016-00171]\]. An autopsy study demonstrated that ulcerated plaque in the aortic arch was frequent in patients with cryptogenic stroke. Nine of 17 patients with ulcerated plaque had lacunar infarction \[[@b4-jos-2016-00171]\]. Another study showed that AA evaluated by computed tomography angiography in patients with cryptogenic stroke was associated with SVDs \[[@b29-jos-2016-00171]\]. However, there is no study evaluating association between AA determined TEE and subtypes of SVDs and AA. In this study, index lacunar infarction was not associated with AA and frequency of lacunar infarction on the TOAST classification in our study was low. These findings might be caused by our classifying methods with the TOAST classification. Using the TOAST classification, we considered CAPs as one of large artery atherosclerosis. Applying the reclassified TOAST classification when CAPs were not considered as one of large artery atherosclerosis, the index lacunar infarction was independently associated with CAP but not with SAP. These findings suggest that AA are associated with both coexisting cerebral SVDs and index acute lacunar infarction.

Pathophysiologies of large artery atherosclerosis and SVDs in ischemic stroke are different. Plaque rupture and artery-to-artery embolism are major mechanisms in large artery atherosclerosis, whereas lipohyalinosis and parent artery atherosclerosis in SVDs \[[@b30-jos-2016-00171]\]. It is uncertain whether AA is merely coexistent or mechanistically connected with SVDs \[[@b14-jos-2016-00171]\]. Exact mechanism for the association between burdens of AA and coexisting SVDs cannot be drawn from our study. Association between AA and SVDs in our study can be explained by the following hypotheses. First, increased arterial stiffness which related with progressed AA may explain the results of our study. In previous studies, increased arterial stiffness was positively associated with larger burden of AA \[[@b31-jos-2016-00171],[@b32-jos-2016-00171]\]. Arterial stiffness increases the pulse pressure and contributes to systemic hypertensive injury \[[@b11-jos-2016-00171]\]. Previous studies showed that the presence of cerebral SVDs was correlated with increased augmentation index and pulse wave velocity which representing arterial stiffness \[[@b28-jos-2016-00171],[@b31-jos-2016-00171],[@b32-jos-2016-00171]\]. Because brain vessels have a low vascular resistance, SVDs are vulnerable to increased pulse pressure \[[@b11-jos-2016-00171]\]. In addition, increased arterial stiffness on CAP comparing with that of SAP in our study may be one of explanation of association with larger burden of AA and progressed SVDs. Second, large artery atherosclerosis and SVDs share common risk factors of ischemic stroke. Old age and chronic hypertension are associated with both AA and SVDs \[[@b33-jos-2016-00171],[@b34-jos-2016-00171]\]. Our study findings are in line with these previous studies. Although the TOAST subtype of large artery atherosclerosis was similar between patients with AA and those without, undetermined two or more causes (mainly large artery atherosclerosis and lacunar infarction) were twice as common in patients with AA. These findings suggest development of stroke in patients with AAs may not be solely dependent on large artery atherosclerosis. Third, inflammatory processes play a key role in the development of both AA and SVDs. Patients with AA had a higher leukocyte count and higher levels of inflammatory cytokines \[[@b35-jos-2016-00171]\]. Similarly, patients with SVDs had higher levels of inflammatory markers \[[@b36-jos-2016-00171]\]. Lastly, SVDs can be derived from emboli itself caused by AA. A clinical study showed that microembolic signals in transcranial Doppler were frequent in patients with AA \[[@b37-jos-2016-00171]\]. Autopsy or clinical studies suggested that thrombotic or cholesterol emboli from ulcerated plaque in AA may cause SVDs \[[@b38-jos-2016-00171]\].

Our study showed that AA was closely related to CMBs. In particular, we firstly demonstrated that strictly lobar CMBs was associated with CAP but not with SAP, whereas non-lobar CMBs was frequent in both CAP and SAP. Pathophysiology of CMBs is known to be different according to location. Non-lobar CMBs is regarded as hypertensive vasculopathy, whereas lobar CMBs is associated with CAA. Relationship between non-lobar CMBs and AA could be explained by their sharing classic vascular risk factors, including hypertension and high pulse pressure, or increased arterial stiffness \[[@b11-jos-2016-00171],[@b32-jos-2016-00171]\]. In contrast, the patients with strictly lobar CMBs may have risk factors of CAA \[[@b39-jos-2016-00171]\]. Because, exact mechanism for association between CAPs and strictly lobar CMBs cannot be identified in our study, further research is mandatory to solve it.

Our study also firstly demonstrated the association between PVSs and AA. A previous study showed that patients with PVSs were more likely to exhibit vascular dementia as opposed to Alzheimer disease \[[@b40-jos-2016-00171]\]. PVS was closely related with WMHs \[[@b41-jos-2016-00171]\], increased blood-brain barrier permeability \[[@b42-jos-2016-00171]\], and inflammatory reaction \[[@b43-jos-2016-00171]\]. However, our results showed that grade of PVSs was associated with burden of AA, the reasons for this association remains uncertain.

We firstly demonstrated that association between total SVD score and burden of AAs. Each component of SVD shares risk factors and mechanisms of developing stroke. In clinical application, it is reasonable to consider various SVD with single representative score. Total SVD score was used to evaluate overall effect of SVD on the brain, rather than estimating the effects of 1 or 2 individual SVDs \[[@b27-jos-2016-00171]\]. Total SVD score was helpful for the rapid quantification or stratification of SVDs. Accordingly, our study gives new information about correlation in burdens of total SVD score and AA.

Our study has limitations. First, although this study was performed in the consecutive ischemic stroke patients who underwent TEE, the possibility of selection bias exists due to the retrospective nature of the analysis. In our hospital, TEE was routine stroke evaluation based on the previous reports of usefulness of TEE in evaluation of potential cardiac or aortic source of embolism \[[@b19-jos-2016-00171],[@b44-jos-2016-00171]\]. However, as routine evaluation of TEE may not be a common practice in other hospitals, it might be difficult to confirm our findings in those hospitals. Nonetheless, this is the largest study that evaluated the association between TEE evaluated AA and SVDs. Second, strictly lobar CMBs were not confirmed by pathological study with presence of CAA. However, other studies were also conducted without pathologic confirmation \[[@b23-jos-2016-00171]\]. Third, small sample size of patients who had strictly lobar CMBs may result in statistical bias. Thus, the relationship between strictly lobar CMBs and CAP cannot be concluded. Therefore, caution must be needed when interpreting our results and further studies are required to identify our results.

Conclusions
===========

In this study, patients with AA frequently had coexisting cerebral SVDs. We also demonstrated that larger burden of AA was associated with coexisting advanced cerebral SVDs. Our findings give an additional information for positive relationship with systemic atherosclerosis and coexisting cerebral SVDs in acute ischemic stroke patients.
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Comparison between performed transesophageal echocardiography (TEE) or not performed
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The frequency of stroke classification according to presence and burden of aortic atheromas (AAs) based on reclassified trial of ORG 10172 in acute stroke treatment (TOAST) classification^\*^
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Multivariable analysis for determining presence of aortic atheroma (AA) after adjusting brachial ankle pulse wave velocity
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Multivariable analysis for determining presence of aortic atheroma (AA) after adjusting reclassified trial of ORG 10172 in acute stroke treatment (TOAST) classification^\*^
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Left arrow: acute infarction on the right basal ganglia in diffusion-weighted imaging. Right white ring: hemorrhagic transformation or cerebral microbleeds on gradient echo imaging. This hypointense lesion was not considered a cerebral microbleed because this area was overlapped with the acute infarction area.

###### 

Classification of white matter changes according to acute infarction. In patients with acute left middle cerebral artery territory infarction, the left side white matter changes were not classified as "white matter hyperintensity (WMH)" because this area was overlapped with the acute infarction area. In contrast, the right side white matter changes were regarded as high-grade periventricular WMH and a cavitary lesion on right side were classified as an asymptomatic lacunar infarction (ALI).

###### 

Flowchart of participants according to inclusion and exclusion criteria.

![Illustrative imaging findings of cerebral small vessel diseases. (A) Cerebral microbleeds (arrows), (B) high-grade white matter hyperintesities (arrows), (C) high-grade perivascular spaces (arrows), and (D) asymptomatic lacunar infarction (arrows).](jos-2016-00171f1){#f1-jos-2016-00171}

![Association between aortic atheroma and burden of cerebral small vessel diseases. Number of CMBs (A), degree of high-grade WMH (B), degree of PVS (C), and total SVD score (D) were highest in patients with CAP, followed by those with SAP, compared to patients without AA (*P* for trend \<0.001). AA, aortic atheroma; CMB, cerebral microbleed; SAP, simple aortic plaque; CAP, complex aortic plaque; WMH, white matter hyperintensity; PVS, perivascular space; SVD, small vessel disease.](jos-2016-00171f2){#f2-jos-2016-00171}

###### 

Demographic characteristics of patients with aortic atheroma (AA)

                                                Total (n=737)   AAs (+) (n=360)   AAs (-) (n=377)   *P* value   CAPs (n=86)   SAPs (n=274)   *P* value^[\*](#tfn1-jos-2016-00171){ref-type="table-fn"}^
  --------------------------------------------- --------------- ----------------- ----------------- ----------- ------------- -------------- ------------------------------------------------------------
  Age (year)                                    63 ± 12         66 ± 9            59 ± 13           0.001       69 ± 8        65 ± 9         0.001
  Sex (male)                                    461 (62.6)      245 (68.1)        216 (57.3)        0.003       68 (79.1)     177 (64.6)     0.012
  Risk factors                                                                                                                               
   Hypertension                                 580 (78.7)      302 (83.9)        278 (73.7)        0.001       69 (80.2)     233 (85.0)     0.314
   Diabetes Mellitus                            248 (33.6)      146 (40.6)        102 (27.1)        0.001       37 (43.0)     109 (39.8)     0.593
   Hyperlipidemia                               56 (7.6)        35 (9.7)          21 (5.6)          0.033       7 (8.1)       28 (10.2)      0.679
   Smoking                                      202 (27.4)      98 (27.2)         104 (27.6)        0.912       30 (34.9)     68 (24.8)      0.072
   Atrial fibrillation                          125 (17.0)      62 (17.2)         63 (16.7)         0.853       14 (16.3)     48 (17.5)      0.949
   Metabolic syndrome                           284 (38.5)      158 (43.9)        126 (33.4)        0.004       31 (36.0)     127 (46.4)     0.106
   Previous stroke                              135 (18.3)      74 (20.6)         61 (16.2)         0.125       14 (16.3)     60 (21.9)      0.288
   Coronary artery disease                      159 (21.6)      103 (28.6)        56 (14.9)         0.001       23 (26.7)     80 (29.2)      0.785
   Congestive heart failure                     29 (3.9)        11 (3.1)          18 (4.8)          0.230       0 (0.0)       11 (4.0)       0.073
  Previous medications                                                                                                                       
   Anti-platelet                                199 (27.0)      104 (28.9)        95 (25.2)         0.259       32 (37.2)     72 (26.3)      0.057
   Anti-coagulant                               51 (6.9)        29 (8.1)          22 (5.8)          0.235       5 (5.8)       24 (8.8)       0.498
   Lipid lowering agents                        94 (12.8)       49 (13.6)         45 (11.9)         0.496       13 (15.1)     36 (13.1)      0.718
  Stroke classification                                                                             0.001                                    0.001
   Large artery atherosclerosis                 186 (25.2)      98 (27.2)         88 (23.3)                     37 (43.0)     61 (22.3)      
   Lacunar infarction                           58 (7.9)        23 (6.4)          35 (9.3)                      0 (0.0)       23 (8.4)       
   Cardioembolism                               174 (23.6)      70 (19.4)         104 (27.6)                    0 (0.0)       70 (25.5)      
   Undetermined two or more causes identified   154 (20.9)      98 (27.2)         56 (14.9)                     49 (57.0)     49 (17.9)      
   Undetermined due to negative evaluation      165 (22.4)      71 (19.7)         94 (24.9)                     0 (0.0)       71 (25.9)      

Values are number (%) or means±standard deviation.

AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.

Comparison between SAPs and CAPs.

###### 

Univariable analysis for association between aortic atheroma (AA) and cerebral small vessel diseases (SVDs)

                                                    Total        AAs (+) (n=360)   AAs (-) (n=377)   *P* value   CAPs (n=86)   SAPs (n=274)   *P* value
  ------------------------------------------------- ------------ ----------------- ----------------- ----------- ------------- -------------- -----------
  Cerebral Microbleeds (CMBs)                                                                                                                 
   Presence                                         161 (21.8)   128 (35.6)        33 (8.8)          \< 0.001    43 (50.0)     85 (31.0)      0.002
   Burden                                                                                            \< 0.001                                 0.002
    CMBs 1-2                                        83 (11.3)    68 (18.9)         15 (4.0)                      26 (30.2)     42 (15.3)      
    CMBs ≥ 3                                        78 (10.6)    60 (16.7)         18 (4.8)                      17 (19.8)     43 (15.7)      
   Distribution                                                                                      \< 0.001                                 0.001
    Strictly lobar                                  8 (1.1)      6 (1.7)           2 (0.5)                       4 (4.7)       2 (0.7)        
    Non-lobar                                       153 (20.8)   122 (33.9)        31 (8.2)                      39 (45.3)     83 (30.3)      
  High-grade white matter hyperintensities (WMHs)   218 (29.6)   158 (43.9)        60 (15.9)         \< 0.001    49 (57.0)     109 (39.8)     0.006
   Periventricular WMHs                             214 (29.0)   157 (43.6)        57 (15.1)         \< 0.001    49 (57.0)     108 (39.4)     0.006
   Deep WMHs                                        176 (23.9)   130 (36.1)        46 (12.2)         \< 0.001    43 (50.0)     87 (31.8)      0.002
  High-grade perivascular spaces                    152 (20.6)   115 (31.9)        37 (9.8)          \< 0.001    40 (46.5)     75 (27.4)      0.001
  Asymptomatic lacunar infarctions                  230 (31.2)   173 (48.1)        57 (15.1)         \< 0.001    52 (60.5)     121 (44.2)     0.009
  Total SVD score                                                                                    \< 0.001                                 0.001
   0                                                466 (63.2)   168 (46.7)        298 (79.0)                    28 (32.6)     140 (51.1)     
   1                                                23 (3.1)     8 (2.2)           15 (4.0)                      0 (0.0)       8 (2.9)        
   2                                                86 (11.7)    52 (14.4)         34 (9.0)                      17 (19.8)     35 (12.8)      
   3                                                82 (11.1)    66 (18.3)         16 (4.2)                      14 (16.3)     52 (19.0)      
   4                                                80 (10.9)    66 (18.3)         14 (3.7)                      27 (31.4)     39 (14.2)      

Values are number (%) or means±SD.

AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.

###### 

Multivariable analysis for association between aortic atheroma (AA) and cerebral small vessel diseases (SVDs)

                                                    Binary logistic regression^[\*](#tfn2-jos-2016-00171){ref-type="table-fn"}^   Multinomial multivariate logistic regression^[\*](#tfn2-jos-2016-00171){ref-type="table-fn"}^                                                     
  ------------------------------------------------- ----------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------- --------------------- ------- ------------------- -------
  Cerebral microbleeds (CMBs)                                                                                                                                                                                                                                                       
  Presence                                          4.68 (3.01-7.28)                                                              0.001                                                                                           8.72 (4.71-16.14)     0.001   3.94 (2.48-6.25)    0.001
  Burden                                                                                                                                                                                                                                                                            
   CMBs 1-2                                         5.54 (3.01-10.19)                                                             0.001                                                                                           12.46 (5.69-27.25)    0.026   4.38 (2.32-8.30)    0.013
   CMBs ≥ 3                                         3.95 (2.19-7.11)                                                              0.022                                                                                           5.70 (2.49-13.03)     0.041   3.56 (1.94-6.53)    0.042
  Distribution                                                                                                                                                                                                                                                                      
   Non-lobar                                        4.61 (2.93-7.25)                                                              0.017                                                                                           7.88 (4.19-14.82)     0.037   3.99 (2.49-6.38)    0.004
   Strictly lobar                                   5.89 (1.07-33.24)                                                             0.001                                                                                           43.32 (5.36-349.54)   0.016   2.60 (0.34-19.77)   0.714
  High-grade white matter hyperintensities (WMHs)   3.13 (2.15-4.57)                                                              0.035                                                                                           5.27 (2.96-9.37)      0.025   2.73 (1.84-4.05)    0.017
   Periventricular WMHs                             3.31 (2.26-4.86)                                                              0.031                                                                                           5.35 (2.43-11.76)     0.021   2.87 (1.93-4.28)    0.012
   Deep WMHs                                        3.01 (2.00-4.53)                                                              0.032                                                                                           5.64 (3.08-10.35)     0.011   2.56 (1.67-3.92)    0.015
  High-grade perivascular spaces                    3.35 (2.17-5.17)                                                              0.038                                                                                           5.70 (3.19-10.19)     0.035   2.74 (1.75-4.31)    0.021
  Asymptomatic lacunar infarctions                  4.24 (2.90-6.20)                                                              0.003                                                                                           6.92 (3.88-12.34)     0.041   3.74 (2.51-5.56)    0.005
  Total SVD score                                                                                                                                                                                                                                                                   
   0                                                Reference                                                                                                                                                                     Reference                     Reference           
   1                                                0.74 (0.30-1.83)                                                              0.521                                                                                           No cases                      0.76 (0.29-1.97)    0.580
   2                                                2.07 (1.24-3.44)                                                              0.035                                                                                           4.76 (2.01-11.28)     0.026   1.75 (1.03-3.03)    0.043
   3                                                6.46 (3.49-1.94)                                                              0.038                                                                                           10.38 (3.94-27.35)    0.041   5.91 (3.17-11.02)   0.032
   4                                                6.10 (3.21-11.62)                                                             0.003                                                                                           18.27 (7.07-47.18)    0.002   4.71 (2.40-9.25)    0.002
  Total SVD score (per 1 point)                     1.63 (1.44-1.85)                                                              0.001                                                                                           1.94 (1.62-2.32)      0.001   1.54 (1.35-1.75)    0.001

OR, Odds ratio; CI, confidence interval; AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.

No AAs as references. Adjusted by age, sex, hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, the prior antiplatelet medication, and stroke subtypes.
